Dublin, July 21, 2021 (GLOBE NEWSWIRE) — The “Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2020-2025) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is estimated to be USD 21.4 Bn in 2020 and is expected to reach USD 26.67 Bn by 2025, growing at a CAGR of 4.5%.Market DynamicsKey factors, such as the rising prevalence of patients suffering from irregular heart rate and rhythm disorder, unhealthy diet habits & changing lifestyle, increasing healthcare expenditure, are likely to contribute to the growth of the market. Technological advancements in the field of CM and CRM devices are bolstering the market growth for CM & CRM Management. The introduction of advanced cardiac devices such as subcutaneous ICDs, Automated External Defibrillators (AEDs), and MRI pacemakers is also expected to propel the market growth.However, the factor such as high treatment cost and high cost of CM & CRM devices hinders market growth. Also, the unfavorable reimbursement policies are impeding the market growth. The strict regulatory requirements and lack of technical expertise in operating Electrocardiography and CRM devices are a challenge for the market’s growth.Market SegmentationThe Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is segmented further based on Type, End-User, and Geography.By Type, the market for Cardiac Monitoring Management Devices is classified as ECG Devices, Event Monitors, and Smart ECG Monitors. Amongst all, the ECG Devices segment is estimated to hold the highest market share. By Type, the Cardiac Rhythm Management Devices Market is segmented as defibrillators and pacemakers. Defibrillators is estimated to hold the highest market share during the forecast period. By End-user, the market is classified as Hospitals; Clinics, Cardiac Centres, and Ambulatory Surgery Centres (ASCs); and Other End Users. Hospital segment holds the highest market share. By Geography, North America accounted for the dominant share of the market. Recent Developments1. Royal Philips, a global leader in health technology, announced that it had completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring – 9th February 20212. Abbott introduces Next-Generation Heart Rhythm Management Devices in Europe, featuring State-Of-The-Art Patient App and Bluetooth Connectivity – 18th February 2020Company ProfilesSome of the companies covered in this report are Medtronic plc, Koninklijke Philips N.V, GE Healthcare, Abbott Laboratories, BTL, BPL Medical Technologies, Boston Scientific Corporation, Hill Rom Holdings Inc, ACS Diagnostics, Biotronik, etc.Competitive QuadrantThe report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments and growth in market share. Why buy this report?

By A Silva